Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Express Scripts
Colorcon
Merck
Medtronic

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Arbaclofen Placarbil

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Arbaclofen Placarbil?

Arbaclofen Placarbil is an investigational drug.

There have been 7 clinical trials for Arbaclofen Placarbil. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2011.

The most common disease conditions in clinical trials are Gastroesophageal Reflux, Disease, and Alcohol Drinking. The leading clinical trial sponsors are Indivior Inc. and [disabled in preview].

There are nineteen US patents protecting this investigational drug and eighty-two international patents.

Recent Clinical Trials for Arbaclofen Placarbil
TitleSponsorPhase
A Phase 1 Bioavailability Study of Arbaclofen Placarbil Modified Release Formulations in Healthy VolunteersIndivior Inc.Phase 1
A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use DisorderIndivior Inc.Phase 2
Efficacy and Safety of Arbaclofen Placarbil in Subjects With Spasticity Due to Multiple SclerosisIndivior Inc.Phase 3

See all Arbaclofen Placarbil clinical trials

Clinical Trial Summary for Arbaclofen Placarbil

Top disease conditions for Arbaclofen Placarbil
Top clinical trial sponsors for Arbaclofen Placarbil

See all Arbaclofen Placarbil clinical trials

US Patents for Arbaclofen Placarbil

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Arbaclofen Placarbil   Start Trial Sustained release oral dosage forms of an R-baclofen prodrug XENOPORT, INC. (Santa Clara, CA)   Start Trial
Arbaclofen Placarbil   Start Trial Acyloxyalkyl carbamate prodrugs, methods of synthesis and use XenoPort, Inc. (Santa Clara, CA)   Start Trial
Arbaclofen Placarbil   Start Trial Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof XenoPort, Inc. (Santa Clara, CA)   Start Trial
Arbaclofen Placarbil   Start Trial Acyloxyalkyl carbamate prodrugs, methods of synthesis and use Xenoport, Inc. (Santa Clara, CA)   Start Trial
Arbaclofen Placarbil   Start Trial Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof XenoPort, Inc. (Santa Clara, CA)   Start Trial
Arbaclofen Placarbil   Start Trial Acyloxyalkyl carbamate prodrugs, methods of synthesis and use XenoPort, Inc. (Santa Clara, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Arbaclofen Placarbil

Drugname Country Document Number Estimated Expiration Related US Patent
Arbaclofen Placarbil Australia 2010221270 2029-03-03   Start Trial
Arbaclofen Placarbil Canada 2753057 2029-03-03   Start Trial
Arbaclofen Placarbil China 102341099 2029-03-03   Start Trial
Arbaclofen Placarbil European Patent Office 2403486 2029-03-03   Start Trial
Arbaclofen Placarbil Israel 214628 2029-03-03   Start Trial
Arbaclofen Placarbil Japan 2012519212 2029-03-03   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Moodys
Merck
Boehringer Ingelheim
Johnson and Johnson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.